Will personalized ultrafractionated stereotactic adaptive radiotherapy (PULSAR) or split-course SBRT based on systemic therapy (3S) be future directions in the Field of SBRT?
Zhou Z, Guan B, Lin J, Zheng R, Xu B.
Int Immunopharmacol. 2025 Jan 27;146:113689. doi: 10.1016/j.intimp.2024.113689. Epub 2024 Dec 24.
PMID:39721852
[Split-course radiotherapy or treatment interruption].
Feasibility of split-course stereotactic ablative radiotherapy for oligometastases.
Paik EK, Kim MS, Seo YS, Jang WI, Kang JK, Cho CK, Yoo HJ.
Jpn J Clin Oncol. 2018 Jun 1;48(6):548-554. doi: 10.1093/jjco/hyy062.
PMID:29722825
Split-course hypofractionated radiotherapy for aged and frail patients with head and neck cancers. A retrospective study of 75 cases.
Benhmida S, Sun R, Gherga E, Hammoud Y, Rouvier J, Mauvais O, Bockel S, Louvrier A, Lebbad A, Bontemps P, Ortholan C, Bourhis J, Lestrade L, Sun XS.
Cancer Radiother. 2020 Dec;24(8):812-819. doi: 10.1016/j.canrad.2020.03.013. Epub 2020 Nov 2.
PMID:33144061
Split-Course Accelerated Hypofractionated Radiotherapy (SCAHRT): A Safe and Effective Option for Head and Neck Cancer in the Elderly or Infirm.
Bledsoe TJ, Noble AR, Reddy CA, Burkey BB, Greskovich JF, Nwizu T, Adelstein DJ, Saxton JP, Koyfman SA.
Anticancer Res. 2016 Mar;36(3):933-9.
PMID:26976981
Split-course radiotherapy with or without concurrent or sequential chemotherapy in non-small cell lung cancer.
Ulutin HC, Güden M, Oysul K, Sürenkök S, Pak Y.
Radiat Med. 2000 Mar-Apr;18(2):93-6.
PMID:10888041
Radical surgery and postoperative split-course radiotherapy in squamous cell carcinoma of the mobile tongue: factors influencing local control and the time to recurrence.